Trial intelligence / Profile preview

PRF vs Hyaluronic Acid in Moderate Knee Osteoarthritis

NCT06797960Phase 1Not yet recruiting

Sponsor
Fayoum University
Start
Feb 2025
Primary completion
Sep 2025
Modality
Device-based Delivery
01

Overview

Phase 1, randomised trial of platelet rich fibrin in knee osteoarthritis (OA) (2 arms), sponsored by Fayoum University. Primary endpoint: Visual Analog Scale for Pain at 3 months. Planned start Feb 2025; status: not yet recruiting.

02

Drugs

platelet rich fibrin
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT06797960.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06797960.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call